Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 3
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
Online download statistics by month:
Online download statistics by month: March 2024 to September 2025
Abstract
Full
Pdf
Mar 2024
700
720
304
Apr 2024
311
312
114
May 2024
154
155
60
Jun 2024
255
257
65
Jul 2024
170
174
71
Aug 2024
124
124
51
Sep 2024
159
158
54
Oct 2024
109
110
52
Nov 2024
138
141
48
Dec 2024
116
118
51
Jan 2025
129
131
46
Feb 2025
197
198
60
Mar 2025
104
105
50
Apr 2025
128
128
73
May 2025
139
139
71
Jun 2025
95
95
59
Jul 2025
1
1
0
Sep 2025
1
1
0
Total
3030
3067
1229
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?